What is the recommended administration schedule for 30 units of Mixtard (biphasic insulin) in an adult patient with type 2 diabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Administering 30 Units of Mixtard (Biphasic Insulin)

For 30 units of Mixtard daily, administer it as a twice-daily regimen with approximately 17-18 units before breakfast and 12-13 units before dinner (roughly 55-60% morning, 40-45% evening split), given 0-15 minutes before meals. 1, 2

Recommended Dosing Schedule

Morning Dose (Before Breakfast)

  • Give 17-18 units (approximately 55-60% of total daily dose) 0-15 minutes before breakfast 1, 2
  • This higher morning dose addresses the dawn phenomenon and provides coverage through the day 2

Evening Dose (Before Dinner)

  • Give 12-13 units (approximately 40-45% of total daily dose) 0-15 minutes before dinner 1, 2
  • The lower evening dose reduces nocturnal hypoglycemia risk while providing overnight basal coverage 2

Critical Administration Requirements

Timing and Meal Consistency

  • Inject Mixtard 0-15 minutes before meals—never after eating 1, 3
  • Take insulin at the same times every day 1
  • Eat meals at consistent times daily to match the fixed insulin action profile 1
  • Never skip meals, as the intermediate-acting component continues working regardless of food intake 1

Carbohydrate Consistency

  • Consume similar amounts of carbohydrates each day to match the set doses of premixed insulin 1
  • Premixed insulin lacks the flexibility of basal-bolus regimens—meal timing and content must be predictable 1

Monitoring Requirements

  • Check fasting blood glucose and pre-dinner glucose daily during titration 1
  • Monitor 2-hour postprandial glucose periodically to assess adequacy of the rapid-acting component 1
  • Reassess therapy every 3-6 months with HbA1c measurement 1

Dose Adjustment Guidelines

If Fasting Glucose Remains Elevated

  • Increase the evening (dinner) dose by 2 units every 3 days until fasting glucose reaches 80-130 mg/dL 4
  • The evening dose primarily controls overnight and fasting glucose 4

If Pre-Dinner Glucose Remains Elevated

  • Increase the morning (breakfast) dose by 2 units every 3 days 4
  • The morning dose provides daytime basal coverage 4

If Hypoglycemia Occurs

  • Reduce the corresponding dose by 10-20% immediately 1
  • Treat any glucose <70 mg/dL with 15-20 grams of fast-acting carbohydrate 1
  • Recheck glucose 15-20 minutes after treatment and repeat if needed 1

Physical Activity Considerations

  • Always carry quick-acting carbohydrates during and after exercise 1
  • Reduce insulin dose or increase carbohydrate intake before planned exercise to prevent hypoglycemia 1
  • Physical activity timing significantly affects hypoglycemia risk with premixed insulin 1

Critical Pitfalls to Avoid

  • Never mix or dilute Mixtard with other insulin formulations 1
  • Do not use Mixtard in hospitalized patients—randomized trials show unacceptably high hypoglycemia rates compared to basal-bolus regimens 1
  • Avoid irregular meal timing or skipping meals, which dramatically increases hypoglycemia risk with fixed-ratio premixed insulin 1
  • Do not continue premixed insulin if flexible meal timing is needed—transition to basal-bolus therapy instead 1

When to Consider Alternative Regimens

  • If total insulin requirements exceed 0.5 units/kg/day without achieving glycemic targets, transition to basal-bolus therapy rather than continuing premixed insulin 1
  • For patients requiring flexible meal patterns, multiple-daily injection basal-bolus regimens are more appropriate than premixed insulin 1
  • Randomized trials demonstrate basal-bolus therapy provides better glycemic control with reduced complications compared to premixed insulin regimens 1

Foundation Therapy

  • Continue metformin (unless contraindicated) when using Mixtard, as this combination provides superior glycemic control with reduced insulin requirements 3
  • Do not abruptly discontinue oral medications when starting insulin due to rebound hyperglycemia risk 3

References

Guideline

Insulin Regimen Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

EADSG Guidelines: Insulin Therapy in Diabetes.

Diabetes therapy : research, treatment and education of diabetes and related disorders, 2018

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the recommended dosage of Insulin Mixtard (Biphasic Isophane Insulin)
What is the recommended dosing regimen for 70/30 (Novolin, Humulin) insulin?
What should be the morning and evening NPH (Novolin N (NPH insulin)) insulin doses and correction scale for a patient with type 2 diabetes mellitus (T2DM) on a norepinephrine (Levophed (norepinephrine)) drip and hydrocortisone (Cortef (hydrocortisone)) 25 mg every 8 hours, with impaired renal function (creatinine 1.14, glomerular filtration rate (GFR) 70), who received continuous renal replacement therapy (CRRT) until yesterday and is scheduled for dialysis today, and has been experiencing hyperglycemia (blood glucose 320-350 mg/dL) despite receiving 30 units of NPH insulin overnight and an additional 17 units of short-acting insulin?
What is the recommended fasting time prior to insulin injection for a patient with diabetes?
What is the recommended morning and evening dose of 70/30 (Novolin 70/30 or Humulin 70/30) insulin?
What does Piaget's theory of concrete operations look like in school-age children with Autism Spectrum Disorder (ASD)?
What is the best course of action for a patient experiencing nervousness and shortness of breath (dyspnea) in the mornings, considering their age, medical history, and potential underlying conditions such as anxiety, depression, chronic obstructive pulmonary disease (COPD), asthma, or cardiac conditions like heart failure?
What are the appropriate evaluation and treatment steps for a patient with a black lesion on the lip, considering potential malignancy and other serious conditions?
Can Januvia (sitagliptin) and Jardiance (empagliflozin) be used together in patients with type 2 diabetes and inadequate glycemic control, particularly those with pre-existing kidney disease or at risk for hypotension?
Can a disc bulge (intervertebral disc protrusion) lead to a herniated disc in adults, particularly those with a history of back strain, degenerative disc disease, or trauma to the spine?
What are the initial laboratory tests for a patient suspected of having alpha 1 antitrypsin deficiency, particularly for an adult presenting with symptoms of Chronic Obstructive Pulmonary Disease (COPD) or liver disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.